|Articles|February 1, 2002

Optimal Cholesterol Management: New Strategies
Volume 8
Issue 2 Suppl

Rising to the Challenge of the New NCEP ATP III Guidelines: Exceeding Current Therapeutic Limitations

Author(s)H. Bryan Brewer, JR, MD

Download PDF: Rising to the Challenge of the New NCEP ATP III Guidelines: Exceeding Current Therapeutic Limitations

Articles in this issue

over 24 years ago

Article

Participating Faculty

over 24 years ago

Article

Introduction

over 24 years ago

Article

State of the Art in Cholesterol Management: Targeting Multiple Pathways

over 24 years ago

Article

Preclinical and Clinical Pharmacology of a New Class of Lipid Management Agents

over 24 years ago

Article

An Investigative Look: Selective Cholesterol Absorption Inhibitors - Embarking on a New Standard of Care

over 24 years ago

Article

Future Outlook: Changing Perspectives on Best Practice

over 24 years ago

Article

Panel Discussion

over 24 years ago

Article

Continuing Medical Education Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

The Timing and Characteristics of Supplemental Indications for Medicines

ByYingying Zhu, PhD,Claire H. Brennan, BA,Haijun Tian, PhD,Josephine N. Tran, PharmD, MS,Peter J. Neumann, ScD,James D. Chambers, PhD,Pei-Jung Lin, PhD,Meng Li, PhD

July 6th 2026

State Medicaid Budgetary Implications of New Cancers

ByAmanda C. Chen, PhD,Anuraag R. Kansal, PhD,David C. Grabowski, PhD

July 2nd 2026

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

ByKaitlyn T. Haas, PharmD,Joseph J. Saseen, PharmD, BCPS, BCACP,Oliver Titus, MS,Nathan Lamberton, PharmD, BCACP,Lisa M. Schilling, MD, MSPH,Keri N. Hogan, PharmD, BCACP,Alison Marks, BA,Sarah J. Billups, PharmD, BCPS

July 1st 2026

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Gabriela Samayoa, MD, MPH,Xue Han, PhD,Deborah Freedman, MBA,Lauren Isenman, MPH,Rashmi Patel, MD, PhD

June 12th 2026

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Rising to the Challenge of the New NCEP ATP III Guidelines: Exceeding Current Therapeutic Limitations

Articles in this issue

Related Content

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Trending on AJMC

Medicare GLP-1 Bridge Launches, but Who Actually Qualifies?

FDA Advisory Committee Supports Moderna mRNA Flu Vaccine Review

Online GLP-1 Sellers Often Skip Clinician Oversight

Early Treatment Succeeds in CRC With Next-Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Real-World Data Show MASH Progresses Faster Than Trials Suggest

Access, Affordability, & Accountability: A New Era in Oncology Reimbursement

Rising to the Challenge of the New NCEP ATP III Guidelines: Exceeding Current Therapeutic Limitations

Articles in this issue

Related Content

The Timing and Characteristics of Supplemental Indications for Medicines

State Medicaid Budgetary Implications of New Cancers

Blood Pressure Control Among Adherent vs Nonadherent Medicare Patients With Hypertension

The Effect of Medicaid Reimbursement for Psychiatrists on the Health Care Burden of Serious Mental Illness

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Trending on AJMC

Medicare GLP-1 Bridge Launches, but Who Actually Qualifies?

FDA Advisory Committee Supports Moderna mRNA Flu Vaccine Review

Online GLP-1 Sellers Often Skip Clinician Oversight

Early Treatment Succeeds in CRC With Next-Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo

Real-World Data Show MASH Progresses Faster Than Trials Suggest